Fritz Van Rhee

45PUBLICATIONS
202CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AllergyMedical virologyCancer therapy (excl. chemotherapy and radiation therapy)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|Aug 22, 2026
Prognostic impact of lymphocyte kinetics and immune composition during bispecific antibody therapy in relapsed/refractory multiple myeloma.

|Aug 11, 2026
Development and Validation of the Idiopathic Multicentric Castleman Disease Symptom Burden Scale (ISBUS): Protocol for an International Multistage Mixed Methods Study.

|Aug 07, 2026
Correction: Clinical outcomes and risk factors of cytomegalovirus reactivation in teclistamab-treated multiple myeloma patients.

|Jul 28, 2026
Efficacy and Safety of CAR-T Cell Therapy and Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma with Renal Impairment: A Propensity Score-Matched Analysis.

|Mar 31, 2026
Clinical outcomes and risk factors of cytomegalovirus reactivation in teclistamab-treated multiple myeloma patients.

Hira Cheema, Asis Shrestha, Syed Naqvi

|Mar 03, 2026
Elucidating the grading intricacies of idiopathic multicentric Castleman disease histopathology: a pathologist's perspective.

Daisy V Alapat, Payam Etebari, Frits Van Rhee

Pageof 8

Frequent Collaborators

25 joint publications

Caroline Schinke

19 joint publications

Samer Al-Hadidi

11 joint publications

David C Fajgenbaum

9 joint publications

Meera Mohan